Abiomed has received US Food and Drug Administration's (FDA) investigational device exemption (IDE) to begin a pivotal clinical study of its Impella Right-side Percutaneous (RP ) pump. The percutaneous heart pump is implanted through a ...
Tags: percutaneous heart pump, Impella Right-side Percutaneous pump, FDA
Abiomed, medical device company, has won FDA 510(k) clearance for new, high flow percutaneous, catheter-based Impella device with peak flows of approximately four liters of blood per minute. The new percutaneous heart pump, which is ...
Tags: Abiomed, Impella Cardiac Power, Impella cVAD